STOCK TITAN

Cemex SAB de CV Financials

CXMSF
FY2024 annual
Revenue $16.2B -2.1% YoY
Net Income $960.0M +382.4% YoY
EPS (Diluted) $0.02 YoY not available
Free Cash Flow $894.0M -34.1% YoY
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2024 Currency USD FYE December

Cemex SAB de CV (CXMSF) reported $16.2B in revenue for fiscal year 2024, down 2.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CXMSF FY2024

CEMEX’s core mechanic is cash-funded deleveraging: operating cash is paying down debt faster than it is building a cash buffer.

The non-obvious shift is balance-sheet repair: long-term debt fell from $7.4B to $5.5B while revenue has mostly plateaued. Because the company is using cash to retire obligations instead of hoarding it, liquidity still looks thin with a current ratio of 0.8x and cash of $864M; the balance sheet is improving, but it still depends on steady operating cash rather than a large cash reserve.

Cash conversion was stronger than headline profit suggests: operating cash flow of $1.9B was about twice net income of $960M. After capital spending of $1.0B, free cash flow was still $894M, which shows the earnings were backed by cash even though reinvestment absorbs a large share of it.

FY2023’s profit dip looks more like a below-the-line distortion than an operating collapse, because operating cash flow still reached $2.2B while net income was only $199M. The clearest clue is the tax swing: tax expense fell from $1.2B to $67M, making profit look more volatile than the underlying cash engine.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Cemex SAB de CV does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
7/8

Cemex SAB de CV passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.97x

For every $1 of reported earnings, Cemex SAB de CV generates $1.97 in operating cash flow ($1.9B OCF vs $960.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$16.2B
YoY-2.1%
5Y CAGR+4.6%

Cemex SAB de CV generated $16.2B in revenue in fiscal year 2024. This represents a decrease of 2.1% from the prior year.

Net Income
$960.0M
YoY+382.4%
5Y CAGR+39.9%

Cemex SAB de CV reported $960.0M in net income in fiscal year 2024. This represents an increase of 382.4% from the prior year.

EPS (Diluted)
$0.02

Cemex SAB de CV earned $0.02 per diluted share (EPS) in fiscal year 2024.

EBITDA

Not reported for fiscal year 2024.

Cash & Balance Sheet

Free Cash Flow
$894.0M
YoY-34.1%
5Y CAGR+4.9%

Cemex SAB de CV generated $894.0M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 34.1% from the prior year.

Cash & Debt
$864.0M
YoY+38.5%
5Y CAGR+1.9%

Cemex SAB de CV held $864.0M in cash against $5.5B in long-term debt as of fiscal year 2024.

Shares Outstanding
14.51B

Cemex SAB de CV had 14.51B shares outstanding in fiscal year 2024.

Dividends Per Share

Not reported for fiscal year 2024.

Margins & Returns

Net Margin
5.9%
YoY+4.7pp
5Y CAGR+4.5pp

Cemex SAB de CV's net profit margin was 5.9% in fiscal year 2024, showing the share of revenue converted to profit. This is up 4.7 percentage points from the prior year.

Return on Equity
7.7%
YoY+6.0pp
5Y CAGR+6.0pp

Cemex SAB de CV's ROE was 7.7% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 6.0 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2024.

Operating Margin

Not reported for fiscal year 2024.

Capital Allocation

Capital Expenditures
$1.0B
YoY+15.6%
5Y CAGR+9.0%

Cemex SAB de CV invested $1.0B in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 15.6% from the prior year.

R&D Spending

Not reported for fiscal year 2024.

Share Buybacks

Not reported for fiscal year 2024.

CXMSF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CXMSF annual income statement
MetricFY24FY23FY22FY21FY20FY19FY18FY17FY17
Revenue$16.2B-2.1%$16.6B+12.6%$14.7B+2.3%$14.4B+13.5%$12.7B-2.2%$13.0B-4.2%$13.5B+4.7%$12.9BN/A
Interest Expense$74.0M+5.7%$70.0M+12.9%$62.0M-7.5%$67.0M-9.5%$74.0M-3.9%$77.0M+4.1%$74.0M+4.2%$71.0MN/A
Income Tax$67.0M-94.4%$1.2B+616.7%$168.0M+22.6%$137.0M+280.6%$36.0M-77.1%$157.0M-29.9%$224.0M+1300.0%$16.0MN/A
Net Income$960.0M+382.4%$199.0M-77.5%$885.0M+13.8%$778.0M+153.8%-$1.4B-907.8%$179.0M-68.6%$570.0M-34.3%$867.0MN/A
EPS (Diluted)$0.02$0.00-72.9%$0.01$0.02+157.3%-$0.03$0.00$0.01-21.6%$0.01N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income.

CXMSF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CXMSF annual balance sheet
MetricFY24FY23FY22FY21FY20FY19FY18FY17FY17
Total Assets$27.3B-4.0%$28.4B+7.5%$26.4B-0.8%$26.6B-2.8%$27.4B-6.6%$29.4B+0.6%$29.2B-2.4%$29.9B$29.8B
Current Assets$5.0B+0.2%$5.0B+10.6%$4.5B+7.1%$4.2B-0.2%$4.2B-7.5%$4.6B+33.8%$3.4B-5.9%$3.6B$4.3B
Cash & Equivalents$864.0M+38.5%$624.0M+26.1%$495.0M-19.2%$613.0M-35.5%$950.0M+20.6%$788.0M+155.0%$309.0M-55.8%$699.0M$561.0M
Inventory$1.5B-17.0%$1.8B+7.2%$1.7B+32.4%$1.3B+29.9%$971.0M-1.8%$989.0M-8.5%$1.1B+12.7%$959.0MN/A
Goodwill$7.4B-3.0%$7.7B+1.8%$7.5B-5.6%$8.0B-6.1%$8.5B-11.0%$9.6B-3.5%$9.9B-0.4%$9.9B$10.0B
Total Liabilities$14.8B-9.2%$16.3B+5.0%$15.5B-5.1%$16.4B-11.3%$18.5B-0.4%$18.5B+2.3%$18.1B-6.0%$19.3B$20.4B
Current Liabilities$6.1B-10.2%$6.8B+22.4%$5.5B+3.1%$5.4B+0.5%$5.4B-1.1%$5.4B+12.8%$4.8B-18.8%$5.9B$4.3B
Long-Term Debt$5.5B-11.2%$6.2B-10.7%$7.0B-5.5%$7.4B-21.0%$9.3B-0.3%$9.4B+0.6%$9.3B-5.7%$9.9B$11.4B
Total Equity$12.5B+3.0%$12.1B+11.1%$10.9B+6.2%$10.3B+14.7%$9.0B-17.3%$10.8B-2.1%$11.1B+4.3%$10.6B$9.5B
Retained Earnings$5.2B+18.5%$4.4B+4.3%$4.2B+25.3%$3.4B+28.6%$2.6B+62.6%$1.6B-0.1%$1.6B+45.5%$1.1B$829.0M

Not reported in any period shown, so not listed: Accounts Receivable.

CXMSF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CXMSF annual cash flow statement
MetricFY24FY23FY22FY21FY20FY19FY18FY17FY17
Operating Cash Flow$1.9B-14.8%$2.2B+62.4%$1.4B-25.8%$1.8B+15.6%$1.6B+17.6%$1.4B-13.5%$1.6B-15.1%$1.8BN/A
Capital Expenditures$1.0B+15.6%$865.0M+14.6%$755.0M-2.7%$776.0M+44.2%$538.0M-17.4%$651.0M+8.3%$601.0M+6.0%$567.0MN/A
Free Cash Flow$894.0M-34.1%$1.4B+121.4%$613.0M-42.5%$1.1B+1.0%$1.1B+50.0%$704.0M-27.1%$966.0M-24.4%$1.3BN/A
Investing Cash Flow-$328.0M+75.2%-$1.3B-106.6%-$640.0M-134.4%-$273.0M-413.8%$87.0M+133.2%-$262.0M+67.9%-$815.0M-247.4%$553.0MN/A
Financing Cash Flow-$1.3B-78.7%-$701.0M+27.1%-$961.0M+48.1%-$1.9B-21.8%-$1.5B-151.7%-$604.0M+48.1%-$1.2B+51.3%-$2.4BN/A
Dividends Paid$90.0MN/AN/AN/AN/A$150.0MN/AN/AN/A
Share BuybacksN/AN/A$111.0M$0-100.0%$83.0M+66.0%$50.0M-33.3%$75.0MN/AN/A

CXMSF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

CXMSF annual financial ratios
MetricFY24FY23FY22FY21FY20FY19FY18FY17FY17
Net Margin5.9%+4.7pp1.2%-4.8pp6.0%+0.6pp5.4%+16.8pp-11.4%-12.8pp1.4%-2.8pp4.2%-2.5pp6.7%N/A
Return on Equity7.7%+6.0pp1.6%-6.5pp8.1%+0.5pp7.6%+23.7pp-16.2%-17.8pp1.7%-3.5pp5.1%-3.0pp8.2%N/A
Return on Assets3.5%+2.8pp0.7%-2.7pp3.4%+0.4pp2.9%+8.2pp-5.3%-5.9pp0.6%-1.3pp1.9%-1.0pp2.9%N/A
Current Ratio0.82+0.1x0.74-0.1x0.820.0x0.790.0x0.79-0.1x0.85+0.1x0.71+0.1x0.620.99
Debt-to-Equity0.44-0.1x0.51-0.1x0.64-0.1x0.72-0.3x1.04+0.2x0.870.0x0.84-0.1x0.931.20
FCF Margin5.5%-2.7pp8.2%+4.0pp4.2%-3.3pp7.4%-0.9pp8.3%+2.9pp5.4%-1.7pp7.1%-2.7pp9.9%N/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Note: The current ratio is below 1.0 (0.82), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is Cemex SAB de CV's annual revenue?

Cemex SAB de CV (CXMSF) reported $16.2B in total revenue for fiscal year 2024. This represents a -2.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cemex SAB de CV's revenue growing?

Cemex SAB de CV (CXMSF) revenue declined by 2.1% year-over-year, from $16.6B to $16.2B in fiscal year 2024.

Is Cemex SAB de CV profitable?

Yes, Cemex SAB de CV (CXMSF) reported a net income of $960.0M in fiscal year 2024, with a net profit margin of 5.9%.

Cemex SAB de CV (CXMSF) reported diluted earnings per share of $0.02 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2024, Cemex SAB de CV (CXMSF) had $864.0M in cash and equivalents against $5.5B in long-term debt.

Cemex SAB de CV (CXMSF) had a net profit margin of 5.9% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Cemex SAB de CV (CXMSF) has a return on equity of 7.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

Cemex SAB de CV (CXMSF) generated $894.0M in free cash flow during fiscal year 2024. This represents a -34.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Cemex SAB de CV (CXMSF) generated $1.9B in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

Cemex SAB de CV (CXMSF) had $27.3B in total assets as of fiscal year 2024, including both current and long-term assets.

Cemex SAB de CV (CXMSF) invested $1.0B in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Cemex SAB de CV (CXMSF) had 14.51B shares outstanding as of fiscal year 2024.

Cemex SAB de CV (CXMSF) had a current ratio of 0.82 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

Cemex SAB de CV (CXMSF) had a debt-to-equity ratio of 0.44 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Cemex SAB de CV (CXMSF) had a return on assets of 3.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Cemex SAB de CV (CXMSF) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Cemex SAB de CV (CXMSF) has an earnings quality ratio of 1.97x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top